MicroRNA-497 suppress osteosarcoma by targeting MAPK/Erk pathway

Area of Science:

• Molecular Biology
• Oncology
• Cell Biology

Background:

• Osteosarcoma is a primary bone malignancy with limited treatment options.
• Understanding the molecular mechanisms of osteosarcoma cell apoptosis is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the role and mechanism of microRNA-497 (miRNA-497) in regulating apoptosis of osteosarcoma cells.
• To explore the potential of miRNA-497 as a therapeutic target for osteosarcoma.

Main Methods:

• MG-63 osteosarcoma cells were transfected with miRNA-497 mimics.
• Cell proliferation was assessed using MTT assay.
• Apoptosis rates were determined by flow cytometry.
• Gene and protein expression of MAPK, Erk, and P21 were analyzed via RT-PCR and Western blot.

Main Results:

• Transfection with miRNA-497 significantly reduced osteosarcoma cell proliferation.
• A notable increase in apoptosis rates was observed in the miRNA-497 group compared to controls (32.17% vs. 8.40%).
• Gene and protein expression levels of MAPK, Erk, and P21 were significantly altered in the miRNA-497 group.

Conclusions:

• MiRNA-497 promotes osteosarcoma cell apoptosis.
• MiRNA-497 functions by inhibiting the MAPK/Erk signaling pathway, leading to the activation of P21.
• These findings highlight miRNA-497 as a potential therapeutic agent for osteosarcoma.